DK3458460T3 - Imidazoler som histondemethylase-inhibitorer - Google Patents

Imidazoler som histondemethylase-inhibitorer Download PDF

Info

Publication number
DK3458460T3
DK3458460T3 DK17723710.4T DK17723710T DK3458460T3 DK 3458460 T3 DK3458460 T3 DK 3458460T3 DK 17723710 T DK17723710 T DK 17723710T DK 3458460 T3 DK3458460 T3 DK 3458460T3
Authority
DK
Denmark
Prior art keywords
histondemethylase
imidazoles
inhibitors
histondemethylase inhibitors
Prior art date
Application number
DK17723710.4T
Other languages
English (en)
Inventor
Paola Vianello
Alessia Romussi
Anna Cappa
Paolo Trifiro'
Mario Varasi
Luca Sartori
Ciro Mercurio
Original Assignee
Inst Europeo Di Oncologia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Europeo Di Oncologia S R L filed Critical Inst Europeo Di Oncologia S R L
Application granted granted Critical
Publication of DK3458460T3 publication Critical patent/DK3458460T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK17723710.4T 2016-05-18 2017-05-18 Imidazoler som histondemethylase-inhibitorer DK3458460T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16170238.6A EP3246330A1 (en) 2016-05-18 2016-05-18 Imidazoles as histone demethylase inhibitors
PCT/EP2017/062009 WO2017198780A1 (en) 2016-05-18 2017-05-18 Imidazoles as histone demethylase inhibitors

Publications (1)

Publication Number Publication Date
DK3458460T3 true DK3458460T3 (da) 2021-03-01

Family

ID=56014931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17723710.4T DK3458460T3 (da) 2016-05-18 2017-05-18 Imidazoler som histondemethylase-inhibitorer

Country Status (8)

Country Link
US (2) US10562914B2 (da)
EP (2) EP3246330A1 (da)
JP (1) JP6972024B2 (da)
CN (1) CN109641918B (da)
AU (1) AU2017266325B2 (da)
CA (1) CA3063785C (da)
DK (1) DK3458460T3 (da)
WO (1) WO2017198780A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3246330A1 (en) 2016-05-18 2017-11-22 Istituto Europeo di Oncologia S.r.l. Imidazoles as histone demethylase inhibitors
AU2018309372B2 (en) 2017-08-03 2024-08-15 Oryzon Genomics, S.A. Methods of treating behavior alterations
HRP20251471T1 (hr) 2019-03-20 2026-01-02 Oryzon Genomics, S.A. Postupci liječenja poremećaja hiperaktivnosti s deficitom pažnje korištenjem inhibitora kdm1a kao što je spoj vafidemstat
SI3941466T1 (sl) 2019-03-20 2026-04-30 Oryzon Genomics, S.A. Vafidemstat za zdravljenje neagresivnih simptomov mejne osebnostne motnje
CN114341366A (zh) 2019-07-05 2022-04-12 奥莱松基因组股份有限公司 用于使用kdm1a抑制剂个体化治疗小细胞肺癌的生物标志物和方法
IT202000007873A1 (it) 2020-04-14 2021-10-14 St Europeo Di Oncologia S R L Molecole per uso nel trattamento delle infezioni virali
WO2022058405A2 (en) 2020-09-16 2022-03-24 Ifom - Istituto Firc Di Oncologia Molecolare Histone deacetylase inhibitors and uses thereof
CA3231846A1 (en) 2021-04-08 2022-10-13 Tamara Maes Combinations of lsd1 inhibitors for treating myeloid cancers
US20250295660A1 (en) 2022-05-09 2025-09-25 Oryzon Genomics, S.A. Methods of treating nf1-mutant tumors using lsd1 inhibitors
US20250275969A1 (en) 2022-05-09 2025-09-04 Oryzon Genomics, S.A. Methods of treating malignant peripheral nerve sheath tumor (mpnst) using lsd1 inhibitors
US20260151399A1 (en) 2022-11-24 2026-06-04 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors and menin inhibitors for treating cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204018A (en) 1990-02-01 1993-04-20 Hoffmann-La Roche Inc. Liquid crystals
GB0321003D0 (en) * 2003-09-09 2003-10-08 Angeletti P Ist Richerche Bio Compounds, compositions and uses
CA2594665A1 (en) 2005-01-19 2006-07-27 Biolipox Ab Thienopyrroles useful in the treatment of inflammation
WO2009121033A2 (en) * 2008-03-27 2009-10-01 University Of Southern California Substituted nitrogen heterocycles and synthesis and uses thereof
US8389580B2 (en) 2009-06-02 2013-03-05 Duke University Arylcyclopropylamines and methods of use
US8765820B2 (en) 2010-04-20 2014-07-01 Universita Degli Studi Di Roma “La Sapienza” Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2
WO2012045883A1 (en) 2010-10-08 2012-04-12 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
GB201017345D0 (en) 2010-10-14 2010-11-24 Proximagen Ltd Receptor antagonists
AU2012207335A1 (en) 2011-01-19 2013-07-25 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
BR112014002939A2 (pt) 2011-08-09 2017-03-01 Takeda Pharmaceuticals Co composto, medicamento, método para profilaxia ou tratamento de doença, a doença sendo esquizofrenia, alzheimer, parkinson ou huntington, uso do composto, e, método para inibir o lsd1
AU2012296639B2 (en) 2011-08-15 2016-06-09 University Of Utah Research Foundation Substituted (E)-N'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhibitors
EP2740474A1 (en) 2012-12-05 2014-06-11 Instituto Europeo di Oncologia S.r.l. Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
WO2014164867A1 (en) * 2013-03-11 2014-10-09 Imago Biosciences Kdm1a inhibitors for the treatment of disease
CA2903081A1 (en) 2013-03-14 2014-09-25 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
CN105555785B (zh) * 2013-06-18 2019-03-01 4Sc股份公司 作为dyrk激酶抑制剂的2,3-二氢苯并呋喃-5-基化合物
CN104278008B (zh) * 2013-07-12 2020-08-21 北京宏冠再生医学科技有限公司 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
EP2993175A1 (en) 2014-09-05 2016-03-09 IEO - Istituto Europeo di Oncologia Srl Thienopyrroles as histone demethylase inhibitors
EP3246330A1 (en) 2016-05-18 2017-11-22 Istituto Europeo di Oncologia S.r.l. Imidazoles as histone demethylase inhibitors

Also Published As

Publication number Publication date
US20200299303A1 (en) 2020-09-24
CA3063785A1 (en) 2017-11-23
EP3458460B1 (en) 2020-12-09
AU2017266325A1 (en) 2019-01-17
US10961255B2 (en) 2021-03-30
JP2019519520A (ja) 2019-07-11
CN109641918B (zh) 2021-12-21
WO2017198780A1 (en) 2017-11-23
US10562914B2 (en) 2020-02-18
US20190152987A1 (en) 2019-05-23
AU2017266325B2 (en) 2021-07-08
EP3246330A1 (en) 2017-11-22
JP6972024B2 (ja) 2021-11-24
EP3458460A1 (en) 2019-03-27
CA3063785C (en) 2024-10-29
CN109641918A (zh) 2019-04-16

Similar Documents

Publication Publication Date Title
CY1125826T1 (el) Ενωσεις αναστολεις της βητα-λακταμασης
IL269196A (en) Novel inhibitors
IL263586A (en) Inhibitors of the menin-mll interaction
EP3541932A4 (en) INHIBITORS OF CRISPR-CAS9
LT3303334T (lt) Tirozinkinazės inhibitoriai
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3442972T3 (da) Bromdomænehæmmere
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3571192T3 (da) Jak1-selektive inhibitorer
HUE042335T2 (hu) ROR-gamma dihidropirrolopiridin inhibitorai
DK3105218T3 (da) Cyclopropylaminer som lsd1-inhibitorer
DK3105226T3 (da) Cyclopropylaminer som lsd1-inhibitorer
DK3286183T3 (da) Isoxazolylsubstituerede benzimidazoler
DK3271349T3 (da) Benzimidazolederivater som bromodomain-inhibitorer
HUE050564T2 (hu) Lizinspecifikus demetiláz-1 inhibitorai
EP3313828A4 (en) METALLO-BETA-Lactamase INHIBITORS
DK3538528T3 (da) Pyrrolamider som alpha v-integrinhæmmere
DK3341379T3 (da) EZH2-hæmmere
DK3288944T3 (da) Imidazopyrazinoner som pde1-inhibitorer
DK3186242T3 (da) Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
DK3544981T3 (da) Benzodiazoliumforbindelser som enac-inhibitorer
DK3630744T3 (da) Pyrazol-magl-inhibitorer
EP3303283A4 (en) Fto inhibitors
MA43367A (fr) Inhibiteurs de métallo-bêta-lactamases